Effects of long-term treatment with trandolapril on augmented vasoconstriction in rats with chronic heart failure

Journal of Cardiac Failure

Volumn 2, Issue 4, 1996, Pages 301-310

  Okumura, Yoko ^a   Nasa, Yoshihisa ^a   Sanbe, Atsushi ^a   Toga, Wakako ^a   Takeo, Satoshi ^a  

^a TOKYO UNIVERSITY OF PHARMACY AND LIFE SCIENCES   (Japan)

Author keywords

Angiotensin; Angiotensin I converting enzyme inhibitor; Norepinephrine; Vascular smooth muscle

Indexed keywords

ANGIOTENSIN II; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; INDOLE DERIVATIVE; NORADRENALIN; PROSTAGLANDIN F; TRANDOLAPRIL; VASOCONSTRICTOR AGENT;

ANALYSIS OF VARIANCE; ANIMAL; ARTICLE; CONGESTIVE HEART FAILURE; CORONARY BLOOD VESSEL; CULTURE TECHNIQUE; DISEASE MODEL; DRUG EFFECT; DRUG INTERACTION; HEMODYNAMICS; MALE; PATHOPHYSIOLOGY; RAT; REFERENCE VALUE; VASCULAR SMOOTH MUSCLE; VASOCONSTRICTION; WISTAR RAT;

ANALYSIS OF VARIANCE; ANGIOTENSIN II; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANIMALS; CORONARY VESSELS; CULTURE TECHNIQUES; DISEASE MODELS, ANIMAL; DRUG INTERACTIONS; HEART FAILURE, CONGESTIVE; HEMODYNAMIC PROCESSES; INDOLES; MALE; MUSCLE, SMOOTH, VASCULAR; NOREPINEPHRINE; PROSTAGLANDINS F; RATS; RATS, WISTAR; REFERENCE VALUES; VASOCONSTRICTION; VASOCONSTRICTOR AGENTS;

EID: 0030344803     PISSN: 10719164     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1071-9164(96)80017-0     Document Type: Article

References (11)

1. Zelis R, Flaim SF: Alterations in vasomotor tone in congestive heart failure. Prog Cardiovasc Dis 1982;24:437-59
2. Drexler H, Hayoz D, Munzel T, Just H, Zelis R, Brunner HR: Endothelial function in congestive heart failure. Am Heart J 1993;126:761-4
3. Luscher TF, Noll G: Endothelium-dependent vasomotion in aging, hypertension, and heart failure. Circulation 1993; 87(suppl VII):VII97-103
4. Kaiser L, Spickard RC, Olivier NB: Heart failure depresses endothelium-dependent responses in canine femoral artery. Am J Physiol 1989;256:H962-7
5. Kubo SH, Rector TS, Bank AJ, Williams RE, Heifetz SM: Endothelium-dependent vasodilation is attenuated in patients with heart failure. Circulation 1991;84:1589-96
6. Ontkean M, Gay R, Greenberg B: Diminished endothelium-derived relaxing factor activity in an experimental model of chronic heart failure. Circ Res 1991;69:1088-96
7. Katz SD, Biasucci L, Sabba C, Strom JA, Jondeau G, Galvao M, Solomon S, Nikolic SD, Forman R, LeJemtel TH: Impaired endothelium-mediated vasodilation in the peripheral vasculature of patients with congestive heart failure. J Am Coll Cardiol 1992;19:918-25
8. Gruetter CA, Ryan ET, Lemke SM, Bailly DA, Fox MK, Schoepp DD: Endothelium-dependent modulation of angiotensin II-induced contraction in blood vessels. Eur J Pharmacol 1988;146:85-95
9. Chatterjee K, Parmley WW: Vasodilator therapy for chronic heart failure. Annu Rev Pharmacol Toxicol 1980;20:475-512
10. Guyatt GH: The treatment of heart failure: a methodological review of the literature. Drugs 1986;32:538-68
11. Packer M: The role of vasodilator therapy in the treatment of severe chronic heart failure. Drugs 1986;32(suppl 5):13-26